Zakrzewski Joseph S - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 18, 2024, Zakrzewski Joseph S's relationship to AN2 Therapeutics, Inc. (ANTX) is Director, and currently has 405,880 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Data Source: SEC.
Zakrzewski Joseph S - Insider Non-Derivative Transactions at ANTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 19, 2024 | Sell -- (Common Stock) | 100000 | 19.11 | 405880 |